Saturday, August 1, 2015

Senate, House Calling on FDA to Address Biosimilars, Drug ...

Senate, House Calling on FDA to Address Biosimilars, Drug ...

www.fdanews.com/.../172384-senate-house-calling-on-fda-to-address-biosi...
8 hours ago - On compounding, the House panel calls for the FDA to provide guidance on how pharmacists can fulfill requests for “office use” compounding before receiving a ...

The FDA has received about 3,000 comments regarding the MOU, though many appear to be form letters drafted by the Alliance for Natural Health, a supporter of compounding pharmacies.

Compounding pharmacy advocacy groups fight FDA's proposed ...

www.rightinginjustice.com/.../compounding-pharmacy-advocacy-groups-fi...
12 hours ago - compounding pharmacy is not allowed under the Federal Food, Drug & Cosmetic Act to ship more than 5 percent of their products across state lines. However ...